36.06
0.03%
0.05
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $36.06, with a volume of 705.66K.
It is up +0.03% in the last 24 hours and down -7.43% over the past month.
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.
See More
Previous Close:
$36.01
Open:
$35.95
24h Volume:
705.66K
Relative Volume:
0.19
Market Cap:
$18.50B
Revenue:
$15.00B
Net Income/Loss:
$2.48B
P/E Ratio:
7.0706
EPS:
5.1
Net Cash Flow:
$514.00M
1W Performance:
-1.56%
1M Performance:
-7.43%
6M Performance:
-11.37%
1Y Performance:
+12.00%
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(847) 948-2000
Address
ONE BAXTER PKWY, DEERFIELD, IL
Baxter International Inc Stock (BAX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
May-30-24 | Initiated | Goldman | Neutral |
May-10-24 | Downgrade | TD Cowen | Buy → Hold |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Mar-29-23 | Initiated | UBS | Neutral |
Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-12-22 | Initiated | Jefferies | Hold |
Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
Feb-18-22 | Reiterated | Raymond James | Outperform |
Feb-18-22 | Reiterated | Stifel | Buy |
Feb-18-22 | Reiterated | UBS | Neutral |
Feb-18-22 | Reiterated | Wells Fargo | Overweight |
Feb-11-22 | Initiated | Goldman | Neutral |
Jan-07-22 | Resumed | Citigroup | Buy |
Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
May-25-21 | Initiated | Barclays | Equal Weight |
Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-06-21 | Downgrade | UBS | Buy → Neutral |
Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
Sep-04-20 | Downgrade | Argus | Buy → Hold |
Jun-24-20 | Initiated | Oppenheimer | Outperform |
Mar-19-20 | Upgrade | Stifel | Hold → Buy |
Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-05-20 | Initiated | Citigroup | Neutral |
Feb-13-20 | Initiated | Goldman | Buy |
Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
Nov-02-18 | Upgrade | Argus | Hold → Buy |
Oct-16-18 | Initiated | Barclays | Underweight |
May-17-18 | Resumed | Piper Jaffray | Overweight |
Feb-06-18 | Reiterated | Citigroup | Neutral |
Jan-03-18 | Initiated | Evercore ISI | Outperform |
Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Oneview and Baxter extend partnership to Canadian market - Yahoo Finance
Baxter could restart some IV lines by week’s end in McDowell County - Business North Carolina
Baxter International Inc. stock rises Monday, still underperforms market - MarketWatch
Employees returning to Helene damaged Baxter plant in Marion - Winston-Salem Journal
Oneview Healthcare and Baxter International Extend Value-Added Reseller Agreement for Two More Years and Expand the Agreement to include Canada - Yahoo Finance
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
US Healthcare Giant Baxter Exits China's IV Therapy Market - Yicai Global
Oneview Healthcare Expands Partnership with Baxter - MSN
Oneview extends patient care platform agreement with Baxter in the US, and now, Canada - MSN
Oneview Healthcare Expands Baxter Partnership and Reports Financial Growth - TipRanks
Baxter (BAX) to Cease IV Solution Operations in China Amid Marke - GuruFocus.com
Baxter Recalls Heparin Sodium Injection Over Elevated Endotoxin Levels - MSN
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International's Quarterly Earnings Preview: What You Need to Know - Nasdaq
Baxter International's Quarterly Earnings Preview: What You Need To Know - Barchart
Baxter kidney care unit building R&D center for excellence in Golden Valley, creating 70 jobs - Star Tribune
Baxter expects to restart IV fluids line at hurricane-hit plant within next week - Reuters
Baxter to restart hurricane-damaged NC plant next week (NYSE:BAX) - Seeking Alpha
Troubles Mount for Baxter as Life2000 Slapped with Another Recall Notice - MD+DI
Baxter International IV plant shut down by Helene expected to restart production this week, CEO says - WCNC.com
Baxter Anticipates Restarting Highest-Throughput IV Solutions Manufacturing Line Within Next Week - XM
Coho Partners Ltd. Purchases New Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International to restart highest-throughput IV solutions manufacturing line next week - Fierce healthcare
National IV Fluid Shortage Could Affect Hospital Surgeries for Weeks - Inc.
Central Coast hospitals face IV fluid shortage after Baxter plant shutdown - KSBW Monterey
IV shortage update: Baxter facility damage after hurricane in North Carolina 2024 - American Medical Association
Baxter International (NYSE:BAX) Stock Rating Upgraded by StockNews.com - MarketBeat
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Hospitals’ IV fluid shortage may impact surgeries for weeks - The Associated Press
Baxter North Carolina facility recovering from Hurricane Helene - BioWorld Online
Baxter IV fluid facility in Marion closed by Helene flooding; bridges to property damaged - McDowell News
IV fluid shortage could impact surgeries for weeks. Here’s what you need to know - Fast Company
Hospitals' IV fluid shortage may impact surgeries for weeks - MSN
IV Fluid Shortage May Impact Surgeries Around the U.S. for Weeks - Medpage Today
Baxter IV fluid shortage affects Yampa Valley Medical Center - Steamboat Pilot & Today
Baxter Aims to Take More New Dialysis Patients After Storm Halt - MSN
Baxter pushes to take more new dialysis patients after storm halt - Crain's Chicago Business
Baxter IV fluid manufacturer says more than 1,000 employees are back at McDowell County plant - McDowell News
Disruption in Production of Intravenous (IV) Fluid Due to Impacts from Hurricane Helene—Update #2 - Virginia Department of Health
Everence Capital Management Inc. Raises Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter aims to restore new dialysis patient starts to pre-hurricane levels by year-end - XM
Baxter Manufacturing Updates - Virginia Department of Health
Baxter aims to restore new dialysis patient access to pre-hurricane levels by year-end - Reuters
HHS Continues Taking Action to Increase Access and Supply of IV Fluids Following Hurricane Helene - Sierra Sun Times
SG Americas Securities LLC Sells 148,072 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Hospital describes conservation measures for IV fluids amid nationwide shortage - WLBT
IV fluids shortage reaches Pacific Northwest; Kadlec says situation is monitored - KEPR 19
MHA Continues to Monitor Baxter IV Solutions Shortage - Michigan Health & Hospital Association
Hurricane-related IV fluid shortage could hurt medical device makers - Reuters
Feds, Baxter begin airlifting medical supplies to curb shortage - Crain's Chicago Business
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene - Benzinga
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):